Atallah, Ehab
Schiffer, Charles A.
Weinfurt, Kevin P.
Zhang, Mei-Jie
Radich, Jerald P.
Oehler, Vivian G.
Pinilla-Ibarz, Javier
Deininger, Michael W. N.
Lin, Li
Larson, Richard A.
Mauro, Michael J.
Moore, Joseph O.
Ritchie, Ellen K.
Shah, Neil P.
Silver, Richard T.
Wadleigh, Martha
Cortes, Jorge
Thompson, James
Guhl, Jessica
Horowitz, Mary M.
Flynn, Kathryn E.
Funding for this research was provided by:
National Cancer Institute (R01 CA184798, R01 CA184798)
Article History
Received: 28 August 2017
Accepted: 20 March 2018
First Online: 2 April 2018
Ethics approval and consent to participate
: The Medical College of Wisconsin/Froedtert Hospital institutional review board (IRB) granted initial approval, followed by approval from the IRBs at each of the participating institutions as follows:Dana-Farber Cancer Institute Institutional Review Board.Duke University Health System Institutional Review Board for Clinical Investigations.Fred Hutchinson Cancer Research Center Institutional Review Board.The University of Utah Institutional Review Board.Wayne State University Institutional Review Board.Liberty Institutional Review Board (IRB of record for Moffitt Cancer Center).MD Anderson Cancer Center Institutional Review Board.Memorial Sloan-Kettering Cancer Center Institutional Review Board.Roswell Park Cancer Institute Institutional Review Board.The University of Chicago Biological Sciences Division Institutional Review Board.University of California San Francisco Institutional Review Board.Emory University Institutional Review Board.Weill Cornell Medical College Institutional Review Board.All subjects provided written informed consent at the site at which they enrolled.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.